Ertugliflozin/metformin regulatory update

Merck and Pfizer said FDA and EMA accepted NDAs and MAAs for review for ertugliflozin, ertugliflozin/sitagliptin and ertugliflozin/metformin to treat Type II diabetes. The PDUFA dates of the 3 NDAs ar...